$NKTR 4 SEC Filings

Filed On	Filing
25 Sep 2026	Form 4: Whitfield Roy A, Director Received 2,000 shares as a grant or award · Granted 4,000 Stock Option
25 Sep 2026	Form 4: Greer R Scott, Director Received 2,000 shares as a grant or award · Granted 4,000 Stock Option
25 Sep 2026	Form 4: Chess Robert, Director Received 2,000 shares as a grant or award · Granted 4,000 Stock Option
25 Sep 2026	Form 4: Brainard Diana, Director Received 2,000 shares as a grant or award · Granted 4,000 Stock Option
25 Sep 2026	Form 4: Ajer Jeffrey Robert, Director Received 2,000 shares as a grant or award · Granted 4,000 Stock Option
20 Aug 2026	Form 4: Zalevsky Jonathan, Chief R&D Officer Sold 186 shares ($13.4K)
20 Aug 2026	Form 4: Robin Howard W, Director Sold 418 shares ($30.1K)
24 Jul 2026	Form 4: Zalevsky Jonathan, Chief R&D Officer Granted 16,500 Stock Option
24 Jul 2026	Form 4: Robin Howard W, Director Granted 57,200 Stock Option
02 Jul 2026	Form 4: Zalevsky Jonathan, Chief R&D Officer Sold 5,681 shares ($398K)
18 Jun 2026	Form 4: Robin Howard W, Director Sold 10,000 shares ($603K) · Sold 10,000 shares ($612K)
17 Jun 2026	Form 4: Zalevsky Jonathan, Chief R&D Officer Sold 5,538 shares ($336K)
21 May 2026	Form 4: Zalevsky Jonathan, Chief R&D Officer Sold 199 shares ($13K)
21 May 2026	Form 4: Robin Howard W, Director Sold 444 shares ($29.1K)
20 Feb 2026	Form 4: Zalevsky Jonathan, Chief R&D Officer Sold 180 shares ($13.1K)
20 Feb 2026	Form 4: Robin Howard W, Director Sold 423 shares ($30.9K)
22 Jan 2026	Form 4: Zalevsky Jonathan, Chief R&D Officer Sold 3,867 shares ($138K)
23 Dec 2025	Form 4: Zalevsky Jonathan, Chief R&D Officer Received 6,250 shares as a grant or award · Granted 25,000 Stock Option
23 Dec 2025	Form 4: Robin Howard W, Director Received 21,667 shares as a grant or award · Granted 86,667 Stock Option
25 Nov 2025	Form 4: Zalevsky Jonathan, Chief R&D Officer Received 2,666 shares as a grant or award · Granted 4,766 Stock Option · Sold 1,157 shares ($62.8K)

Comments